Status:
COMPLETED
Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease
Lead Sponsor:
Manchester University NHS Foundation Trust
Conditions:
Pancreatic Ductal Adenocarcinoma
Eligibility:
All Genders
16-100 years
Brief Summary
The aim of this study is to assess whether prehabilitation supervised by an appropriate multimodality team improves indices of sarcopenia in patients scheduled to undergo pancreatoduodenectomy.
Detailed Description
Cachexia is a hallmark feature of pancreatic cancer. Patients with features of cachexia have worse clinical outcomes. This includes a reduction in quality of life, reduced tolerance of therapy and a p...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients treated by pancreatic resection
- Surgery for malignancy
- Patients aged over 16
- CT scans available for assessment
- Exclusion criteria
- Patients scheduled for fast-track pancreatic resection as part of the jaundice pathway
- Aged under 16
- Patients not undergoing pancreatic resection
Exclusion
Key Trial Info
Start Date :
October 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT03770117
Start Date
October 4 2018
End Date
July 1 2019
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, Gtr Manchester, United Kingdom, M13 9WL